76 related articles for article (PubMed ID: 8476435)
1. Expression of the dystrophin gene in cultured fibroblasts.
Hugnot JP; Gilgenkrantz H; Chafey P; Lambert M; Eveno E; Kaplan JC; Kahn A
Biochem Biophys Res Commun; 1993 Apr; 192(1):69-74. PubMed ID: 8476435
[TBL] [Abstract][Full Text] [Related]
2. Towards a therapeutic inhibition of dystrophin exon 23 splicing in mdx mouse muscle induced by antisense oligoribonucleotides (splicomers): target sequence optimisation using oligonucleotide arrays.
Graham IR; Hill VJ; Manoharan M; Inamati GB; Dickson G
J Gene Med; 2004 Oct; 6(10):1149-58. PubMed ID: 15386737
[TBL] [Abstract][Full Text] [Related]
3. Illegitimate transcription. Application to the analysis of truncated transcripts of the dystrophin gene in nonmuscle cultured cells from Duchenne and Becker patients.
Chelly J; Gilgenkrantz H; Hugnot JP; Hamard G; Lambert M; Récan D; Akli S; Cometto M; Kahn A; Kaplan JC
J Clin Invest; 1991 Oct; 88(4):1161-6. PubMed ID: 1918370
[TBL] [Abstract][Full Text] [Related]
4. A case of Becker muscular dystrophy resulting from the skipping of four contiguous exons (71-74) of the dystrophin gene during mRNA maturation.
Patria SY; Alimsardjono H; Nishio H; Takeshima Y; Nakamura H; Matsuo M
Proc Assoc Am Physicians; 1996 Jul; 108(4):308-14. PubMed ID: 8863344
[TBL] [Abstract][Full Text] [Related]
5. Dystrophin gene transcribed from different promoters in neuronal and glial cells.
Chelly J; Hamard G; Koulakoff A; Kaplan JC; Kahn A; Berwald-Netter Y
Nature; 1990 Mar; 344(6261):64-5. PubMed ID: 2406613
[TBL] [Abstract][Full Text] [Related]
6. Expression of recombinant dystrophin and its localization to the cell membrane.
Lee CC; Pearlman JA; Chamberlain JS; Caskey CT
Nature; 1991 Jan; 349(6307):334-6. PubMed ID: 1824797
[TBL] [Abstract][Full Text] [Related]
7. Alternative splicing of human dystrophin mRNA generates isoforms at the carboxy terminus.
Feener CA; Koenig M; Kunkel LM
Nature; 1989 Apr; 338(6215):509-11. PubMed ID: 2648158
[TBL] [Abstract][Full Text] [Related]
8. Characterization of genetic deletions in Becker muscular dystrophy using monoclonal antibodies against a deletion-prone region of dystrophin.
Le Thiet Thanh ; Nguyen Thi Man ; Hori S; Sewry CA; Dubowitz V; Morris GE
Am J Med Genet; 1995 Aug; 58(2):177-86. PubMed ID: 8533812
[TBL] [Abstract][Full Text] [Related]
9. Transcription of the dystrophin gene in human muscle and non-muscle tissue.
Chelly J; Kaplan JC; Maire P; Gautron S; Kahn A
Nature; 1988 Jun; 333(6176):858-60. PubMed ID: 3290682
[TBL] [Abstract][Full Text] [Related]
10. A novel cryptic exon in intron 2 of the human dystrophin gene evolved from an intron by acquiring consensus sequences for splicing at different stages of anthropoid evolution.
Dwi Pramono ZA; Takeshima Y; Surono A; Ishida T; Matsuo M
Biochem Biophys Res Commun; 2000 Jan; 267(1):321-8. PubMed ID: 10623618
[TBL] [Abstract][Full Text] [Related]
11. Six novel transcripts that remove a huge intron ranging from 250 to 800 kb are produced by alternative splicing of the 5' region of the dystrophin gene in human skeletal muscle.
Surono A; Takeshima Y; Wibawa T; Pramono ZA; Matsuo M
Biochem Biophys Res Commun; 1997 Oct; 239(3):895-9. PubMed ID: 9367866
[TBL] [Abstract][Full Text] [Related]
12. Pseudoexon activation in the DMD gene as a novel mechanism for Becker muscular dystrophy.
Tuffery-Giraud S; Saquet C; Chambert S; Claustres M
Hum Mutat; 2003 Jun; 21(6):608-14. PubMed ID: 12754707
[TBL] [Abstract][Full Text] [Related]
13. A polymerase chain reaction screening strategy for the promoter of the canine dystrophin gene.
Schatzberg S; Olby N; Steingold S; Keene B; Atkins C; Meurs K; Solomon G; Goedegebuure SA; Wilton S; Sharp N
Am J Vet Res; 1999 Sep; 60(9):1040-6. PubMed ID: 10490068
[TBL] [Abstract][Full Text] [Related]
14. Disruption of the splicing enhancer sequence within exon 27 of the dystrophin gene by a nonsense mutation induces partial skipping of the exon and is responsible for Becker muscular dystrophy.
Shiga N; Takeshima Y; Sakamoto H; Inoue K; Yokota Y; Yokoyama M; Matsuo M
J Clin Invest; 1997 Nov; 100(9):2204-10. PubMed ID: 9410897
[TBL] [Abstract][Full Text] [Related]
15. [Therapy of Duchenne muscular dystrophy with umbilical cord blood stem cell transplantation].
Zhang C; Feng HY; Huang SL; Fang JP; Xiao LL; Yao XL; Chen C; Ye X; Zeng Y; Lu XL; Wen JM; Zhang WX; Li Z; Feng SW; Xu HG; Huang K; Zhou DH; Chen W; Xie YM; Xi J; Zhang M; Li Y; Liu Y
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2005 Aug; 22(4):399-405. PubMed ID: 16086277
[TBL] [Abstract][Full Text] [Related]
16. The human dystrophin gene requires 16 hours to be transcribed and is cotranscriptionally spliced.
Tennyson CN; Klamut HJ; Worton RG
Nat Genet; 1995 Feb; 9(2):184-90. PubMed ID: 7719347
[TBL] [Abstract][Full Text] [Related]
17. Infidelity in the structure of ectopic transcripts: a novel exon in lymphocyte dystrophin transcripts.
Roberts RG; Bentley DR; Bobrow M
Hum Mutat; 1993; 2(4):293-9. PubMed ID: 8401537
[TBL] [Abstract][Full Text] [Related]
18. DNA sequence analysis for structure/function and mutation studies in Becker muscular dystrophy.
Hamed S; Sutherland-Smith A; Gorospe J; Kendrick-Jones J; Hoffman E
Clin Genet; 2005 Jul; 68(1):69-79. PubMed ID: 15952989
[TBL] [Abstract][Full Text] [Related]
19. Point mutations in the dystrophin gene: evidence for frequent use of cryptic splice sites as a result of splicing defects.
Tuffery-Giraud S; Chambert S; Demaille J; Claustres M
Hum Mutat; 1999; 14(5):359-68. PubMed ID: 10533061
[TBL] [Abstract][Full Text] [Related]
20. Antisense oligonucleotide-induced exon skipping restores dystrophin expression in vitro in a canine model of DMD.
McClorey G; Moulton HM; Iversen PL; Fletcher S; Wilton SD
Gene Ther; 2006 Oct; 13(19):1373-81. PubMed ID: 16724091
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
